Apogee Therapeutics (APGE) Q3 2024 Earnings

12AugConfirmed
Q4 2023
Q2 2024
Q3 2024
-0.65
-0.63
-0.61
-0.59

Details

Expected EPS
-0.598333
Actual EPS
-0.6
Surprise EPS
-0
Surprise Percent
+0.28%

Description

Apogee Therapeutics (APGE) has reported earnings of -0.6 per share for Q3 2024.

0 Comments

Share your thoughts